Lijuan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lijuan Chen has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Erqing Huang
Department of Obstetrics and Gynecology, Union hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications- Hao Zhou
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
2 shared publications - Xiaoli Wang
Department of Obstetrics and Gynecology, Union hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Bin Hu
Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, China
1 shared publication - Chunting Wang
Department of Emergency Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
1 shared publication - Dan Li
Department of Food Science and Technology National University of Singapore Singapore Singapore
1 shared publication
Latest Publications
- Open Access
- 4 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-21
Identified endoplasmic reticulum stress-related molecular cluster and immune characterization in endometriosis
Endometriosis is a common disease among women of childbearing age, and endoplasmic reticulum stress (ERS), a response involved in regulating protein homeostasis, has been linked to its pathogenesis. To identify ERS-related hub genes, this study sequentially employed differential expression analysis, weighted gene co-expression network analysis (WGCNA), protein–protein interaction (PPI) network construction, and three machine learning algorithms. These methods led to the identification of four hub genes: Von Willebrand factor (VWF), vascular cell adhesion molecule 1 (VCAM1), endothelial PAS domain protein 1 (EPAS1), and coagulation factor VIII (F8). Unsupervised cluster analysis was conducted to categorize samples into ERS clusters, and the CIBERSORT algorithm was used to calculate immune infiltration scores, revealing two stable clusters. Cluster B was defined as “immune-enriched” with significantly higher immune scores, while Cluster A was “less immune-enriched”. Functional enrichment analysis of differentially expressed genes (DEGs) between the clusters highlighted cell adhesion and regulation of immune cell activation as key to cluster-specific phenotypes. A diagnostic model built with the four hub genes showed robust utility via validation curves, confirming their clinical relevance. DEGs from each cluster were screened in the Connectivity Map database to identify cluster-specific therapeutic agents. RT-qPCR and immunohistochemistry (IHC) validated that both mRNA and protein levels of the four hub genes were elevated in endometriosis tissues, supporting the bioinformatics findings. Overall, this study links ERS-related hub genes to endometriosis subtyping, immune infiltration, and diagnostics, providing a basis for personalized treatments and a potential clinical tool.
- 4 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-21
Open AccessIdentified endoplasmic reticulum stress-related molecular cluster and immune characterization in endometriosis
Endometriosis is a common disease among women of childbearing age, and endoplasmic reticulum stress (ERS), a response involved in regulating protein homeostasis, has been linked to its pathogenesis. To identify ERS-related hub genes, this study sequentially employed differential expression analysis, weighted gene co-expression network analysis (WGCNA), protein–protein interaction (PPI) network construction, and three machine learning algorithms. These methods led to the identification of four hub genes: Von Willebrand factor (VWF), vascular cell adhesion molecule 1 (VCAM1), endothelial PAS domain protein 1 (EPAS1), and coagulation factor VIII (F8). Unsupervised cluster analysis was conducted to categorize samples into ERS clusters, and the CIBERSORT algorithm was used to calculate immune infiltration scores, revealing two stable clusters. Cluster B was defined as “immune-enriched” with significantly higher immune scores, while Cluster A was “less immune-enriched”. Functional enrichment analysis of differentially expressed genes (DEGs) between the clusters highlighted cell adhesion and regulation of immune cell activation as key to cluster-specific phenotypes. A diagnostic model built with the four hub genes showed robust utility via validation curves, confirming their clinical relevance. DEGs from each cluster were screened in the Connectivity Map database to identify cluster-specific therapeutic agents. RT-qPCR and immunohistochemistry (IHC) validated that both mRNA and protein levels of the four hub genes were elevated in endometriosis tissues, supporting the bioinformatics findings. Overall, this study links ERS-related hub genes to endometriosis subtyping, immune infiltration, and diagnostics, providing a basis for personalized treatments and a potential clinical tool.
- Open Access
- 23 January 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (2) , 142
Regulated Cell Death in Endometriosis
Regulated cell death (RCD) represents a distinct mode of cell demise, differing from accidental cell death (ACD), characterized by specific signaling cascades orchestrated by diverse biomolecules. The regular process of cell death plays a crucial role in upholding internal homeostasis, acting as a safeguard against biological or chemical damage. Nonetheless, specific programmed cell deaths have the potential to activate an immune–inflammatory response, potentially contributing to diseases by enlisting immune cells and releasing pro-inflammatory factors. Endometriosis, a prevalent gynecological ailment, remains incompletely understood despite substantial progress in unraveling associated signaling pathways. Its complexity is intricately tied to the dysregulation of inflammatory immune responses, with various RCD processes such as apoptosis, autophagic cell death, pyroptosis, and ferroptosis implicated in its development. Notably, limited research explores the association between endometriosis and specific RCD pathways like pyroptosis and cuproptosis. The exploration of regulated cell death in the context of endometriosis holds tremendous potential for further advancements. This article thoroughly reviews the molecular mechanisms governed by regulated cell death and their implications for endometriosis. A comprehensive understanding of the regulated cell death mechanism in endometriosis has the potential to catalyze the development of promising therapeutic strategies and chart the course for future research directions in the field.
- 23 January 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (2) , 142
Open AccessRegulated Cell Death in Endometriosis
Regulated cell death (RCD) represents a distinct mode of cell demise, differing from accidental cell death (ACD), characterized by specific signaling cascades orchestrated by diverse biomolecules. The regular process of cell death plays a crucial role in upholding internal homeostasis, acting as a safeguard against biological or chemical damage. Nonetheless, specific programmed cell deaths have the potential to activate an immune–inflammatory response, potentially contributing to diseases by enlisting immune cells and releasing pro-inflammatory factors. Endometriosis, a prevalent gynecological ailment, remains incompletely understood despite substantial progress in unraveling associated signaling pathways. Its complexity is intricately tied to the dysregulation of inflammatory immune responses, with various RCD processes such as apoptosis, autophagic cell death, pyroptosis, and ferroptosis implicated in its development. Notably, limited research explores the association between endometriosis and specific RCD pathways like pyroptosis and cuproptosis. The exploration of regulated cell death in the context of endometriosis holds tremendous potential for further advancements. This article thoroughly reviews the molecular mechanisms governed by regulated cell death and their implications for endometriosis. A comprehensive understanding of the regulated cell death mechanism in endometriosis has the potential to catalyze the development of promising therapeutic strategies and chart the course for future research directions in the field.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
- Open Access
- 9 March 2023
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 21 (1) , 1-17
RNA N6-methyladenosine modification in female reproductive biology and pathophysiology
Gene expression and posttranscriptional regulation can be strongly influenced by epigenetic modifications. N6-methyladenosine, the most extensive RNA modification, has been revealed to participate in many human diseases. Recently, the role of RNA epigenetic modifications in the pathophysiological mechanism of female reproductive diseases has been intensively studied. RNA m6A modification is involved in oogenesis, embryonic growth, and foetal development, as well as preeclampsia, miscarriage, endometriosis and adenomyosis, polycystic ovary syndrome, premature ovarian failure, and common gynaecological tumours such as cervical cancer, endometrial cancer, and ovarian cancer. In this review, we provide a summary of the research results of m6A on the female reproductive biology and pathophysiology in recent years and aim to discuss future research directions and clinical applications of m6A-related targets. Hopefully, this review will add to our understanding of the cellular mechanisms, diagnostic biomarkers, and underlying therapeutic strategies of female reproductive system diseases.
- 9 March 2023
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 21 (1) , 1-17
Open AccessRNA N6-methyladenosine modification in female reproductive biology and pathophysiology
Gene expression and posttranscriptional regulation can be strongly influenced by epigenetic modifications. N6-methyladenosine, the most extensive RNA modification, has been revealed to participate in many human diseases. Recently, the role of RNA epigenetic modifications in the pathophysiological mechanism of female reproductive diseases has been intensively studied. RNA m6A modification is involved in oogenesis, embryonic growth, and foetal development, as well as preeclampsia, miscarriage, endometriosis and adenomyosis, polycystic ovary syndrome, premature ovarian failure, and common gynaecological tumours such as cervical cancer, endometrial cancer, and ovarian cancer. In this review, we provide a summary of the research results of m6A on the female reproductive biology and pathophysiology in recent years and aim to discuss future research directions and clinical applications of m6A-related targets. Hopefully, this review will add to our understanding of the cellular mechanisms, diagnostic biomarkers, and underlying therapeutic strategies of female reproductive system diseases.
- Open Access
- 1 January 2015
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2015, 1-12
The Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF-κB Pathway in Mice
A new approach to treat infections of highly pathogenic influenza virus is to inhibit excessive innate immune response. JiuWei QiangHuo decoction has been used for centuries for the treatment of pulmonary disorders in China. In this study, we evaluated the anti-inflammatory activities of the modified JiuWei QiangHuo (MJWQH) decoction in the treatment of influenza A (H1N1) virus-induced severe pneumonia in mice. The results showed that MJWQH significantly increased the survival rate of H1N1-infected mice and suppressed the production of TNF-α, IL-1, IL-6, MCP-1, RANTES, and IFN-αon day 4 after infection. Moreover, oral administration of MJWQH efficiently inhibited virus replication and alleviated the severity of lung injuries. The results also showed that MJWQH may have potential therapeutic effect on severe lung injury induced by H1N1 virus by regulating the NF-κB pathway. Our study suggested that MJWQH might be an alternative therapy for the treatment of viral pneumonia.
- 1 January 2015
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2015, 1-12
Open AccessThe Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF-κB Pathway in Mice
A new approach to treat infections of highly pathogenic influenza virus is to inhibit excessive innate immune response. JiuWei QiangHuo decoction has been used for centuries for the treatment of pulmonary disorders in China. In this study, we evaluated the anti-inflammatory activities of the modified JiuWei QiangHuo (MJWQH) decoction in the treatment of influenza A (H1N1) virus-induced severe pneumonia in mice. The results showed that MJWQH significantly increased the survival rate of H1N1-infected mice and suppressed the production of TNF-α, IL-1, IL-6, MCP-1, RANTES, and IFN-αon day 4 after infection. Moreover, oral administration of MJWQH efficiently inhibited virus replication and alleviated the severity of lung injuries. The results also showed that MJWQH may have potential therapeutic effect on severe lung injury induced by H1N1 virus by regulating the NF-κB pathway. Our study suggested that MJWQH might be an alternative therapy for the treatment of viral pneumonia.
- 11 July 2012
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 68 (4) , 353-361
IFN‐γ Inhibits Osteopontin Expression in Human Decidual Stromal Cells and can be Attenuated by 1α,25‐Dihydroxyvitamin D3
Problem: The effect of IFN‐γ on the expression of osteopontin (OPN), in the presence or absence of 1α,25‐dihydroxyvitamin D3 (1,25(OH)2D3), in decidual stromal cells (DSC).Method of study: Decidual stromal cells were isolated from women undergoing elective termination of pregnancy (gestational age, 6–9 weeks). After characterization, they were treated with IFN‐γ in the presence or absence of 1,25(OH)2D3. The uterus of pregnancy IFN‐γ knockout mice were collected on gestation day (gd) 7.5, and the expression of OPN were examined.Results: IFN‐γ drastically decreased the expression of OPN in DSC, which was reverted by the addition of 1,25(OH)2D3 to the IFN‐γ‐treated decidual cells. Moreover, the OPN expression in uterus of IFN‐γ knockout mice was higher than that of wild‐type counterparts.Conclusions: We demonstrated OPN was expressed in DSC in human first‐trimester decidua and in the uterus in mice at 7.5 gd. The OPN expression was closely correlated with regulation of IFN‐γ and 1,25(OH)2D3 in human early pregnancy. OPN expression in DSC was significantly decreased with the treatment of IFN‐γ. 1,25(OH)2D3 played an opposite role in IFN‐γ‐mediated inhibition of OPN expression in human DSC.
- 11 July 2012
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 68 (4) , 353-361
IFN‐γ Inhibits Osteopontin Expression in Human Decidual Stromal Cells and can be Attenuated by 1α,25‐Dihydroxyvitamin D3
Problem: The effect of IFN‐γ on the expression of osteopontin (OPN), in the presence or absence of 1α,25‐dihydroxyvitamin D3 (1,25(OH)2D3), in decidual stromal cells (DSC).Method of study: Decidual stromal cells were isolated from women undergoing elective termination of pregnancy (gestational age, 6–9 weeks). After characterization, they were treated with IFN‐γ in the presence or absence of 1,25(OH)2D3. The uterus of pregnancy IFN‐γ knockout mice were collected on gestation day (gd) 7.5, and the expression of OPN were examined.Results: IFN‐γ drastically decreased the expression of OPN in DSC, which was reverted by the addition of 1,25(OH)2D3 to the IFN‐γ‐treated decidual cells. Moreover, the OPN expression in uterus of IFN‐γ knockout mice was higher than that of wild‐type counterparts.Conclusions: We demonstrated OPN was expressed in DSC in human first‐trimester decidua and in the uterus in mice at 7.5 gd. The OPN expression was closely correlated with regulation of IFN‐γ and 1,25(OH)2D3 in human early pregnancy. OPN expression in DSC was significantly decreased with the treatment of IFN‐γ. 1,25(OH)2D3 played an opposite role in IFN‐γ‐mediated inhibition of OPN expression in human DSC.
- 1 October 2010
- Published by Springer Nature in Current Medical Science
- Vol. 30 (5) , 594-598
IL-10 enhances promoter activity of ILT4 gene and up-regulates its expression in THP-1 cells
This study examined the effect of IL-10 on immunoglobulin-like transcript (ILT4) expression of human monocytic leukemic cell line THP-1, especially the role of the ILT4 promoter activity. ILT4 promoter area was amplified by PCR, and was cloned into the eukaryotic expressing vector pGL3-Basic. The pGL3-ILTP obtained was tested by double endonuclease digestion and sequencing. Then, the recombinant plasmid was transfected into THP-1 cells by using lipofectamine. After culture with IL-10 for 12 h, the mRNA extracted from THP-1 cells was detected by RT-PCR and the protein was detected by FACS. The dual-luciferase reporter assay system was employed to detect the activity of ILT4 promoter with or without IL-10. The results showed that the activity of pGL3-ILTP was significantly increased and was more than ten times that of pGL3-Basic cells. After culture with IL-10 for 12 h, the expression of ILT4 protein and its mean fluorescence intensity (MFI) were increased. Moreover, the mRNA was remarkably higher than that of the control group. Dual-luciferase reporter assay revealed that ILT4 promoter was much more activated after being treated with IL-10. We were led to conclude that pGL3-ILTP containing ILT4 promoter was constructed successfully. The expression of ILT4 could be up-regulated by IL-10 both at the transcriptional and translational level. Furthermore, ILT4 promoter could be much more active after addition of IL-10. This study suggests that IL-10 up-regulates ILT4 expression on monocytes via increasing ILT4 gene promoter activity, which may have implication for inducing transplantation tolerance in clinical practice.
- 1 October 2010
- Published by Springer Nature in Current Medical Science
- Vol. 30 (5) , 594-598
IL-10 enhances promoter activity of ILT4 gene and up-regulates its expression in THP-1 cells
This study examined the effect of IL-10 on immunoglobulin-like transcript (ILT4) expression of human monocytic leukemic cell line THP-1, especially the role of the ILT4 promoter activity. ILT4 promoter area was amplified by PCR, and was cloned into the eukaryotic expressing vector pGL3-Basic. The pGL3-ILTP obtained was tested by double endonuclease digestion and sequencing. Then, the recombinant plasmid was transfected into THP-1 cells by using lipofectamine. After culture with IL-10 for 12 h, the mRNA extracted from THP-1 cells was detected by RT-PCR and the protein was detected by FACS. The dual-luciferase reporter assay system was employed to detect the activity of ILT4 promoter with or without IL-10. The results showed that the activity of pGL3-ILTP was significantly increased and was more than ten times that of pGL3-Basic cells. After culture with IL-10 for 12 h, the expression of ILT4 protein and its mean fluorescence intensity (MFI) were increased. Moreover, the mRNA was remarkably higher than that of the control group. Dual-luciferase reporter assay revealed that ILT4 promoter was much more activated after being treated with IL-10. We were led to conclude that pGL3-ILTP containing ILT4 promoter was constructed successfully. The expression of ILT4 could be up-regulated by IL-10 both at the transcriptional and translational level. Furthermore, ILT4 promoter could be much more active after addition of IL-10. This study suggests that IL-10 up-regulates ILT4 expression on monocytes via increasing ILT4 gene promoter activity, which may have implication for inducing transplantation tolerance in clinical practice.